These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 22159460)
21. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma]. Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153 [TBL] [Abstract][Full Text] [Related]
22. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125 [TBL] [Abstract][Full Text] [Related]
23. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645 [TBL] [Abstract][Full Text] [Related]
24. Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis. Arakawa Y; Kajino K; Kano S; Tobita H; Hayashi J; Yasen M; Moriyama M; Arakawa Y; Hino O Biochem Biophys Res Commun; 2004 Sep; 322(1):297-302. PubMed ID: 15313206 [TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
26. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608 [TBL] [Abstract][Full Text] [Related]
27. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma. Jain S; Chen S; Chang KC; Lin YJ; Hu CT; Boldbaatar B; Hamilton JP; Lin SY; Chang TT; Chen SH; Song W; Meltzer SJ; Block TM; Su YH PLoS One; 2012; 7(4):e35789. PubMed ID: 22536438 [TBL] [Abstract][Full Text] [Related]
29. Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma. Zhang T; Guan G; Chen T; Jin J; Zhang L; Yao M; Qi X; Zou J; Chen J; Lu F; Chen X Asia Pac J Clin Oncol; 2018 Oct; 14(5):e352-e358. PubMed ID: 29749051 [TBL] [Abstract][Full Text] [Related]
30. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047 [TBL] [Abstract][Full Text] [Related]
31. Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma. He Y; Cui Y; Xu B; Gu J; Wang W; Luo X PLoS One; 2014; 9(1):e87994. PubMed ID: 24498236 [TBL] [Abstract][Full Text] [Related]
32. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma. Yasen M; Kajino K; Kano S; Tobita H; Yamamoto J; Uchiumi T; Kon S; Maeda M; Obulhasim G; Arii S; Hino O Clin Cancer Res; 2005 Oct; 11(20):7354-61. PubMed ID: 16243807 [TBL] [Abstract][Full Text] [Related]
33. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
34. Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma. Ding S; Gong BD; Yu J; Gu J; Zhang HY; Shang ZB; Fei Q; Wang P; Zhu JD World J Gastroenterol; 2004 Dec; 10(23):3433-40. PubMed ID: 15526362 [TBL] [Abstract][Full Text] [Related]
35. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445 [TBL] [Abstract][Full Text] [Related]
36. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Yang B; Guo M; Herman JG; Clark DP Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151 [TBL] [Abstract][Full Text] [Related]
37. Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation. Tai BJ; Yao M; Zheng WJ; Shen YC; Wang L; Sun JY; Wu MN; Dong ZZ; Yao DF Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):158-163. PubMed ID: 30692043 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma. Xie B; Zhou J; Yuan L; Ren F; Liu DC; Li Q; Shu G Hum Pathol; 2013 May; 44(5):795-801. PubMed ID: 23123137 [TBL] [Abstract][Full Text] [Related]
39. [Expression and methylation status of Foxp3 in human hepatocellular carcinoma]. Dang S; Chen P; Zhang B; Zhou J; Shi L Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):616-9. PubMed ID: 25243964 [TBL] [Abstract][Full Text] [Related]
40. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma. Zhang C; Guo X; Jiang G; Zhang L; Yang Y; Shen F; Wu M; Wei L Int J Cancer; 2008 Sep; 123(5):998-1004. PubMed ID: 18546260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]